Overall Technical outlook

Price Summary

On 2026-02-25, ZYDUSLIFE's stock started at 903.5, reached a high of 921.0, fell to 902.1, and ended 1.79% higher at 919.65, with 564412 shares traded.
The peak price for the stock in the past 52 weeks is 1047.85, with the lowest price being 822.1.

Technicals

Support and Resistance: The price of 919.65 is supported at 901.45 and encounters resistance at 920.25. This suggests key levels where the price might find stability, with 901.45 providing a base and 920.25 acting as an upper boundary for ZYDUSLIFE.
ZYDUSLIFE supportResistance b97626
Support/Resistance for ZYDUSLIFE


Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
ZYDUSLIFE aroon b97626
Aroon chart for Zydus Lifesciences Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
ZYDUSLIFE bbands b97626
Bolinger Bands chart for Zydus Lifesciences Limited


Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for ZYDUSLIFE.
ZYDUSLIFE psar b97626
Parabolic Stop and Reverse chart for Zydus Lifesciences Limited


Stochastic: The current state of the STOCHASTIC is neutral for ZYDUSLIFE, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
ZYDUSLIFE stoch b97626
Stochastic chart for Zydus Lifesciences Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
ZYDUSLIFE trippleSMA b97626
Tripple SMA chart for Zydus Lifesciences Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.